Page last updated: 2024-12-05

acetylhydrazine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Acetylhydrazine, also known as acetohydrazide, is a colorless, crystalline solid with a melting point of 67°C. It is a derivative of hydrazine, with an acetyl group attached. It is commonly synthesized by the reaction of hydrazine hydrate with acetic anhydride or acetyl chloride. Acetylhydrazine is primarily used as a precursor in the synthesis of various pharmaceuticals, agrochemicals, and other organic compounds. Notably, it serves as a key starting material for the production of the antituberculosis drug isoniazid. Additionally, acetylhydrazine finds applications in the preparation of hydrazones, which are compounds with diverse uses in organic synthesis and medicinal chemistry. Research into acetylhydrazine focuses on its potential as a precursor for novel drug candidates, its biological activity, and its potential environmental impact. It is also studied for its role in the synthesis of other valuable compounds.'

acetylhydrazine: metabolite of isoniazid in animals and humans; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

acetohydrazide : A carbohydrazide that is hydrazine in which one of the hydrogens is replaced by an acetyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID14039
CHEMBL ID3091859
CHEBI ID2422
CHEBI ID48978
MeSH IDM0063871

Synonyms (69)

Synonym
sk0dpc9098 ,
hydrazid kyseliny octove
unii-sk0dpc9098
EN300-18497
BB 0240991
monoacetylhydrazine
acetyl hydrazide
n-acetylhydrazine
nsc 53155
hydrazine, acetyl-
nsc-2271
acetic acid, hydrazide
nsc2271
acetyl hydrazine
ethanehydrazonic acid
acethydrazide
wln: zmv1
acetic hydrazide
acetic acid hydrazide
acetohydrazide
ent-61241
monoacetyl hydrazine
CHEBI:2422 ,
nsc-53155
nsc53155
einecs 213-948-7
hydrazid kyseliny octove [czech]
ccris 4791
ai3-61241
nsc 2271
ALD3.1-H_000633
acn2 deriv
ALD3-H_000034
ALD3.1-H_000952
ALD3.1-H_000314
CHEBI:48978
acetohydrazonic acid
1068-57-1
acetylhydrazine
C07447
acethydrazide, 90%
acethydrazine
A0789
oflxlncgoduuot-uhfffaoysa-
inchi=1/c2h6n2o/c1-2(5)4-3/h3h2,1h3,(h,4,5)
AKOS000104423
A801521
BP-30010
FT-0621734
BBL018600
AM20080014
AB00888
CHEMBL3091859
acetohydrazine
acetyl hydrazine contains~10% acetic acid
acetic acid hydrazone
ethanoic acid hydrazide
ethanoic hydrazide
DTXSID9020900
J-519529
mfcd00007610
GS-3116
CS-D1403
Z58981787
Q4678005
STL194154
acethydrazide (moist with methylene chloride)
acetic-2,2,2-d3 acid hydrazide
AB6005

Research Excerpts

Actions

ExcerptReferenceRelevance
"Acetylhydrazine did not produce detectable lesions in organs other than the liver, despite the occurrence of covalent binding to protein in those organs."( Acetylhydrazine hepatotoxicity: the role of covalent binding.
Timbrell, JA; Woodward, KN, 1984
)
2.43

Toxicity

ExcerptReferenceRelevance
" These results implicated H2O2, a cellular mediator of inflammation, as a potential risk factor for the manifestation of adverse drug reactions, particularly those caused by hydrazine containing drugs."( Role of hydrazine in isoniazid-induced hepatotoxicity in a hepatocyte inflammation model.
Mashregi, M; O'Brien, PJ; Tafazoli, S, 2008
)
0.35

Pharmacokinetics

ExcerptReferenceRelevance
" The results suggested that the pharmacokinetic behavior of Iso in rats belonged to a 2-compartment model."( Effects of rifampicin on pharmacokinetics of isoniazid and its metabolite acetylhydrazine in rats.
Cheng, WB; Li, D; Wang, ZY; Zhang, RL, 1992
)
0.51
" This pharmacokinetic analysis, however, also shows that the apparent plasma half-life of acetylhydrazine is about five times longer than the plasma half-life of isoniazid, and thus repeated doses of isoniazid should lead to an accumulation of acetylhydrazine in the slowest acetylators in which the plasma half-life of acetylhydrazine is 20-plus hr."( Pharmacokinetics of the toxic hydrazino metabolites formed from isoniazid in humans.
Lauterburg, BH; Mitchell, JR; Smith, CV; Todd, EL, 1985
)
0.49
" The drug-drug interactions between the anti-retroviral and anti-tubercular drugs are not clearly defined and hence, this study was conducted to evaluate the pharmacokinetic drug-drug interactions of Zidovudine (AZT) with Isoniazid (INH) and its hepatotoxic metabolites."( Investigations on the Influence of Zidovudine in the Pharmacokinetics of Isoniazid and Its Hepatotoxic Metabolites in Rats.
Ramanathan, R; Sivanesan, K, 2019
)
0.51

Bioavailability

ExcerptReferenceRelevance
" In silico ADMET properties, and toxicity studies corroborated that compounds were found to have good bioavailability and less toxic."( Ligand-based designing of DPP-4 inhibitors via hybridization; synthesis, docking, and biological evaluation of pyridazine-acetohydrazides.
Gupta, P; Kumar, V; Mahapatra, A; Nidhar, M; Singh, RK; Tewari, AK; Yadav, BK, 2023
)
0.91

Dosage Studied

ExcerptRelevanceReference
"Male rats and rabbits were singly dosed with either 1-[14C]acetyl isoniazid (acetylisonicotinoylhydrazine, acetyl-INH, 200 mg/kg po) or 1-[14C]acetylhydrazine (50 or 100 mg/kg ip)."( Metabolism of [14C]acetylisoniazid and [14C]acetylhydrazine by the rat and rabbit.
Thomas, BH; Whitehouse, LW; Zeitz, W, 1984
)
0.73
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
drug metabolitenull
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
carbohydrazideA hydrazide consisting of hydrazine carrying one or more carboacyl groups.
carbohydrazonic acidA carbohydrazonic acid is an acid in which the carbonyl oxygen atom of the carboxylic acid group has been replaced by =NNH2.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1059234Lipophilicity, log P of the compound2013European journal of medicinal chemistry, , Volume: 70Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.
AID1059233Antitubercular activity against Mycobacterium tuberculosis BCG2013European journal of medicinal chemistry, , Volume: 70Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.
AID1328437Antibacterial activity against Escherichia coli K-12 BW25113 measured every 10 mins after 24 hrs in presence of biotin2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
A cell-based approach to characterize antimicrobial compounds through kinetic dose response.
AID1328436Antibacterial activity against Escherichia coli K-12 BW25113 measured every 10 mins after 24 hrs in absence of biotin2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
A cell-based approach to characterize antimicrobial compounds through kinetic dose response.
AID1328438Inhibition of Escherichia coli His-tagged bioA at 1 uM using KAPA as substrate after 20 mins in presence of SAM relative to control2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
A cell-based approach to characterize antimicrobial compounds through kinetic dose response.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (61)

TimeframeStudies, This Drug (%)All Drugs %
pre-199023 (37.70)18.7374
1990's8 (13.11)18.2507
2000's4 (6.56)29.6817
2010's12 (19.67)24.3611
2020's14 (22.95)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 50.49

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index50.49 (24.57)
Research Supply Index4.22 (2.92)
Research Growth Index4.95 (4.65)
Search Engine Demand Index79.51 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (50.49)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.52%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other65 (98.48%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]